Posts By :



150 150 marketing

We are grateful and proud to announce that we closed a new financing round last month. We would like to welcome the new partners joining Tricopharming’s capital, PedroDiazMontañez and the two investment funds, KiraVentures and Sancus Capital, which we met thanks to the program organized by Decelera Ventures in September 2021. 

In addition to the investment round, Tricopharming received two support lines in recent months: a NEOTEC financing of €260.000 and an ENISA of the value of €200.000 under the AgroInnpulso financing line.

Tricopharming, based in Barcelona and an experimental R&D centre on the island of Tenerife, was incorporated in October 2018, focusing on improving the productivity of the cultivation of medicinal and aromatic plants through the development of technologies capable of stimulating plant trichomes or plant hairs.

This round is in addition to the 2020 pre-seed round and will drive the market launch, commercialization and development of the new MapStimulants line of bio-agriculture products for medicinal and aromatic plants. One of the star products of this line is Tricostimulant™, a specific biostimulant for medicinal cannabis and fibre hemp crops capable of accelerating production while increasing the content of therapeutic molecules and fibre in the plant, thus increasing crop productivity.

“In this new business stage, our challenge is to enter the international market of agrotech solutions that provide the botanical extracts production sector with more eficiency and eficiency thanks to the application of new technologies to agriculture sector. Agrotech solutions like ours contribute to the positive impact on the environment by achieving greater agricultural sustainability,” says Chiara Sanseverino, co-founder and CFO.

Furthermore, the round aims to boost the internationalisation process and finance the upscaling of the production and commercialisation of the Artennua® product line. Artennua® has been launched on the market after managing to substantially optimise the output of the Artemisia annua plant, thanks to the use of proprietary technology based on plant biostimulation. In this way, we have obtained a unique ingredient with a very high concentration of active ingredients. It has been market in the animal health and natural cosmetics market since 2019.


150 150 marketing

Finally we can announce that we are on the official list of beneficiaries of the NEOTEC program of the Center for Industrial Technological Development CDTI and the Ministry of Science and Innovation.

This program gives a boost to technology startups like ours to continue growing and developing our projects MAPStimulants and Artennua®. Thanks to this financial support, which is in addition to others previously received by Enisa, MINECO, ICEX and ACCIÓ, we will be able to accelerate our trichome revolution throughout 2022.

In Biotech Tricopharming Research SL, we are very proud to achieve this milestone and we thank the CDTI that once again trusts us. We will make the most of this valuable opportunity.


150 150 marketing

We joined with Sequentia Biotech, to integrate our workflows and provide an end to end solution for research and development of biostimulants.

We take care from field testing to bioinformatics analysis, to test and analyze the effectiveness of an already existing biostimulant, or an in-house tailored made to fit your needs.


150 150 marketing

Artemisia annua is an aromatic herbaceous plant native to Asia, a species that stands out from the rest of its genus as an excellent and important source of clinically proven therapeutic compounds. Artemisia annua L. produces a range of complex terpenoids in its trichomes, among which artemisinin is of particular interest for the treatment of a variety of pathologies.

Uses in ancient times

For some, the name artemisia derives from the Greek goddess of hunting and forests, Artemisia, who according to tradition was the first to taste it and discover its virtues. While for others the name comes from the Greek word “artemes” which means “of good health”. It was considered a magical herb, believed to be useful to keep away negative spirits. Artemisia is a genus of plants known since ancient times for their various and numerous healing properties, but it is in China that these species have become particularly well known and recognized for their various health properties. It was traditionally used to treat fever. It was rediscovered in 1970 when the Chinese Manual of Prescriptions for Emergency Treatments (340 B.C.) was found.

Therapeutic uses

Its medicinal properties were rediscovered by modern science in the 1970s when research revealed that the plant contains more than 10 active substances that act together or in parallel. In 1971, scientists demonstrated that extracts of the plant had antimalarial activity in primate models, and in 1972, the active ingredient, artemisinin, was isolated and its chemical structure described. The therapeutic substances contained in the plant are artemisinin, eupatorin, casticin, artemetin, phenolic acids and coumarins. Artemisinin is its main component and is found in the glandular trichomes of the leaves, stems and inflorescences. It is concentrated mainly in the upper parts of the plant where new growth occurs. 

Modern uses

In general, artemisia is a plant with a sedative and expectorant effect and also has antiseptic, antispasmodic, carminative and digestive, emmenagogue, expectorant and antidiabetic properties. Scientific studies have shown that the components within the leaves of Artemisia annua, which can be ingested in capsules, extracts or teas, have significant activity against breast and prostate cancer without serious side effects. Artemisia annua has also been shown to be effective against a wide range of pet cancers and leishmaniasis. Prevention, as they say, is even better than a cure. Artemisia annua and its derivatives are being studied for preventive effects. When taken at recommended dosages it does not give side effects and could even protect against the development of diseases, from infections to cancers.

Artennua®, optimized version of Artemisia annua

Artennua® is our optimized version of the Artemisia annua plant; improved thanks to our 100% natural technology that increases the content of botanical active ingredients. 

The production of Artennua® is based on a unique and patented technology called TricoStimulant™, a 100% natural smart agrotechnical solution in the form of a biostimulant specifically aimed at enhancing medicinal and aromatic plants. 

The mechanism of action of TricoStimulant™ technology is based on stimulating plant trichomes (glandular structures) to produce more molecules of interest. After many years of R&D, the technology has been incorporated into the cultivation of the Artemisia annua plant and has created a new brand of an optimized version of the plant under the brand name Artennua®. 

Artennua is therefore the result of applying the unique Tricostimulant™ technology to plants in the field, during the flowering cycle. Today the largest production originates from an organic farm in the Canary Islands.


150 150 marketing

Tricopharming is from now on and for the next 24 months, part of the ICEX-Next Export Initiation Program, with the support of ICEX and the co-financing of European FEDER fund. The purpose of this program is to contribute to design the strategy and to identify the necessary steps to develop the international expansion of the Tricopharming company and its products, including Artennua.


150 150 marketing

Cannabis (or hemp) is a flowering plant from the family Cannabaceae, a subset of the order of Urticales. There are three species: Sativa, Indica and Ruderalis and several subspecies. Physically, even with considerable variations, it has an average height of 1.5 – 2 meters and is characterized by palmed leaves and straight, hairy stems. 

The name “hemp” means the variety without psychoactive ingredient (in nature, usually the male of the plant), which is used to produce food (seeds, oil, flour), biofuel, paper, fabrics, stringwork, cosmetic products and materials (innovative and very efficient) and for ecological construction.

History and uses in ancient times

Hemp is a plant that has been with humanity for thousands of years. Originally from the regions of Central Asia, over the centuries it has spread almost everywhere, overcoming all kinds of environmental adversities.  This was one of the first plants that man used as fiber, food, medicine and in social and religious rituals.

The first recorded use of cannabis dates back to 8.000 B.C., in an old town of Taiwan. It was used for the production of the first fabrics for clothing and also for the manufacture of footwear. In 4.000 B.C. In a Chinese town called Pan-p’o, hemp was considered one of the “five grains” of China and therefore one of the main food crops.

In India, Cannabis has been used for various medicinal and spiritual purposes, ranging from nausea and diarrhea to headaches and insomnia. Most importantly, the Indians used Cannabis often enough to ease the pain of childbirth.

Active molecules and therapeutical uses

Cannabis contains a huge amount of active ingredients. In more than 600 substances that make up it we find terpenes (more than 200), hydrocarbons, flavonoids, fatty acids, alcohols, aldehydes and other substances, in addition to the approximately 120 cannabinoids that have been identified to date. The distribution of cannabinoids varies in different strains of cannabis and usually only three or four cannabinoids are found in a plant at concentrations above 0.1%. The most well-known molecules contained in this plant are undoubtedly s-9-tetraidrocannabinole (THC), cannabidiole (CBD) and cannabigerole (CBG).

  • Terpenes are the class of chemicals with the greatest variety of smells and flavors. They contribute significantly to the quality of fruits and vegetables and participate in the synthesis of different biochemicals such as vitamins, hormones, oils and cannabinoids and have different therapeutic properties. Several terpenes have been identified with therapeutic effects on cannabis, such as myrcene, limonene, β-cariophyllene and pinene.
  • THC is the only cannabinoid that has psychoactive properties. Extensive research in recent decades explains that THC has numerous medicinal properties that are useful in a wide range of ailments, some of which include: Alzheimer’s disease, atherosclerosis, glaucoma, multiple sclerosis, Parkinson’s disease, sleep apnea, Tourette’s syndrome, cancer (in various forms) and many others. THC also has antiemetic (anti-nausea) properties that make it useful for the treatment of AIDS and chemotherapy patients. THC is considered a neuroprotective and means it can protect brain cells from damage caused, for example, by inflammation and oxidative stress. Scientists have also shown that THC can promote the growth of new brain cells through a process known as neurogenesis.
  • CBD is another cannabinoid currently at the center of various scientific research for its therapeutic qualities. Not only that, because the ownership of CBD to counteract the psychoactive effects of THC, has also seen the entry of this cannabinoid into the recreational cannabis sector with many strains that have been enriched with CBD in proportions of 1: 1, 2: 1 or higher than THC. In addition to studies such as antipsychotic and pain therapy, CBD and cannabis genetics with a high content of this cannabinoid are the focus of several trials and clinical studies on different forms of drug-resistant epilepsy, especially in paediatric cases and young patients.
  • CBG is one of the many cannabinoids in cannabis and hemp that does not have psychotropic properties. Like THC and CBD, CBG produces various effects on our body, which makes it an increasingly attractive substance. Among others, we find antibacterial and antifungal effects, it can inhibit the growth of cancer cells, relieves pain, is anti-inflammatory, promotes bone growth, helps to fall asleep, is useful in the treatment of anorexia and cachexia, improves the intestinal diseases, it is antidepressant, it lowers intraocular pressure and many studies have confirmed that it is useful in the treatment of glaucoma.
Industrial uses

The industrial uses of the hemp plant are so many. The main uses are in the food sector, in the production of paper, in green construction, in the production of bioplastics, biofuels, textilesand cosmetics.

  1. The part of the plant that is mainly used as food is the seed, but the inflorescences are mainly marketed to make infusions or fermented to make tasty craft beers. The seeds can be eaten whole or peeled, they can be squeezed or ground to obtain hemp oil and flour. 
  2. The part of the plant that is used in construction is the gutter. It is the woody inner part that constitutes the stem of the plant. Hemp is rich in silicon, which gives it insulating and extremely absorbent properties. Thanks to the recent improvement of the properties of hemp in construction, several companies have embarked on the production of thermoacoustic panels, bricks and biocomposites such as lime. 
  3. From hemp it is possible to produce a completely natural, biodegradable and compostable bioplastic that could compete with the price of petroleum-derived materials that are used today, but that would have better characteristics of resistance and lightness. The automotive industry is one of the main users of this product, which makes it possible to manufacture lighter and more efficient cars, but also the packaging sector, for example, is paying a lot of attention to this type of material. In addition to being a bioplastic, hemp can be used as a biofuel, a natural and sustainable fuel source.

The part of the plant that is used for weaving is the fibrous part, these are hollow fibers, hydroscopic and resistant to mechanical action and deformation. The result is a breathable and heat-insulating fabric that allows you to stay cool in summer and warm in winter, reflecting up to 95% of UVA rays, hypoallergenic and antiseptic.


150 150 marketing

El Referente, in collaboration with the EIT Food iVZW organization founded by the European Union, has published the Map of the Agrotech ecosystem in Spain, made up of public-private actors and 143 startups, among which we have been highlighted as a company working on digitization and technological evolution within the agricultural world.

Thanks to the emergence of new projects and initiatives aimed at overcoming the difficulties of a sector that sometimes shows production systems stuck in the past. The report of investment in innovative companies in the Agri-Food-Tech world has increased by 15.5% in 2020, reaching $26.1 billion.

“The health and social crisis has reminded us that for employment, social activity and services to work, the primary sectors must do so. The 2020 scenario has brought back some general recognition to the agricultural and livestock sector, enhancing, in turn, debates on the quality and origin of products and evidencing the resilience and innovation opportunities existing in the primary sector.

Agrotech in Spain is one of the sectors that has experienced the greatest resilience and attraction of capital in 2020.

Read the full article here:


150 150 marketing

We have received recognition from the Chamber of Commerce of Santa Cruz de Tenerife for our contribution to youth employment. This recognition is due to our collaboration in the Integral Program of Qualification and Employment (PICE) and our commitment to improve the employability rates of young people under 30 years old.

The company Biotech Tricopharming Research SL has been the beneficiary of a hiring aid, within the Youth Employment Initiative of the European Social Fund and with the co-financing of the Cabildo de Tenerife, whose objective is to integrate into the labor market young people who do not work, study or receive training, in order to promote the labor market integration of the young population. It has been supported by the PICE program of the Chamber of Commerce, Industry, Services and Navigation of Santa Cruz de Tenerife.


150 150 marketing

We thank ICEX España Exportación e Inversiones and the European Regional Development Fund for their support in our project BIOMAPs: Research on new industrial applications of Artennua® and identification and development of new biostimulants.

In the framework of the project, the results of our research in 2020 on Artennua® derivatives in industrial applications such as biocides, food preservatives and flavorings were very promising.

Moreover, thanks to the BIOMAPPs project we could accelerate the trials on optimization of different medicinal and aromatic plants species cultivation with the application of our technology ᴛʀɪᴄᴏsᴛɪᴍᴜʟᴀɴᴛ™.


150 150 marketing

Within the framework of the XV Meeting of Plant Molecular Biology organized by the Spanish Technology Platform for Plant Biotechnology BIOVEGEN, the “COMPANY-FINANCING R&D Session” will be celebrated. As part of the association we have the honor to be represented by the founder, scientist and CEO of Biotech Tricopharming Research SL, Luis Matías Hernández. The objective of the session will be to present TRICOPHARMING’s experience as a source of innovation, its business development strategy and the advances in the R&D projects carried out and in progress. The session will be carried out this 27th of November via online. 

Here is the preliminary program:

Moderator: Gonzaga Ruiz de Gauna. BIOVEGEN
11:00 h

Innovation companies:

  • DVA IBERIA. Andrés de La Cruz. Director of Crop Protection.
  • MAFA BIOSCIENCE. Hanan El Bakkali. Director of Regulatory Affairs.
  • TRICOPHARMING- Luis Matías Hernández. CEO and Co-Founder.
  • TARAZONA. Sergio Monzón. Director of Innovation and R+D.

Management and financing: 

  • CDTI-Centro Desarrollo Tecnológico Industrial. Carlos Sanchez. Biotechnology and Agrifood Department.
  • AEI-State Research Agency. Mª Ángeles Ferre. Thematic Scientific-Technical Programs.
  • BIOVEGEN-Technological Platform of Plant Biotechnology. Gonzaga Ruiz de Gauna. Coordinator.